Studies exploring the influence of MS13 on NCI-H520 and NCI-H23 lung cancer cells showed that MS13 promotes anti-proliferation and apoptosis activity in NSCLC, involving the PI3K-AKT axis, cell cycle-apoptosis, and MAPK signaling pathways [161]. Here, AKT1 is linked to non-small cell lung carcinoma.